Baird Financial Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Buy |
|
|||||
|
2025
Q1 | $1.22M | Sell |
|
|||||
|
2024
Q4 | $8.27M | Buy |
|
|||||
|
2024
Q3 | $7.11M | Buy |
|
|||||
|
2024
Q2 | $4.78M | Buy |
|
|||||
|
2024
Q1 | $3.82M | Buy |
|
|||||
|
2023
Q4 | $2.82M | Sell |
|
|||||
|
2023
Q3 | $2.45M | Sell |
|
|||||
|
2023
Q2 | $3.13M | Buy |
|
|||||
|
2023
Q1 | $607K | Buy |
|
|||||
|
2022
Q4 | $238K | Sell |
|
|||||
|
2022
Q3 | $324K | Buy |
|
|||||
|
2022
Q2 | $330K | Buy |
|
|||||
|
2022
Q1 | $391K | Sell |
|
|||||
|
2021
Q4 | $545K | Sell |
|
|||||
|
2021
Q3 | $658K | Buy |
|
|||||
|
2021
Q2 | $498K | Sell |
|
|||||
|
2021
Q1 | $710K | Sell |
|
|||||
|
2020
Q4 | $478K | Sell |
|
|||||
|
2020
Q3 | $470K | Sell |
|
|||||
|
2020
Q2 | $713K | Buy |
|
|||||
|
2020
Q1 | $406K | Sell |
|
|||||
|
2019
Q4 | $751K | Sell |
|
|||||
|
2019
Q3 | $3.05M | Buy |
|
|||||
|
2019
Q2 | $3.42M | Buy |
|